Collagen and Gelatin Market

The global collagen and gelatin market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $1.6 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising incidence of chronic diseases, increasing demand for collagen and gelatin due to increased demand for wound care products, and strong emphasis on the launch of novel products by key market players are driving the market growth.

Attractive Opportunities in the Collagen and Gelatin Market

To know about the assumptions considered for the study, Request for Free Sample Report

Collagen and Gelatin Market Dynamics

DRIVER: Growing incidence of Chronic wounds, diabetes, and cancer

The prevalence of diabetes makes it a significant target indication due to its association with complex wound complications, including infections, ulcerations (such as leg or foot ulcers), and surgical wounds. Treating these complications incurs high medical expenses. In the US, approximately 25% of individuals with diabetes develop foot ulcers at some point in their lives, and around 15% of the diabetic population experiences diabetic foot ulcers (DFUs). As the prevalence of DFUs continues to rise, there is an increasing demand for regenerative medicine products such as grafts and matrices.

RESTRAINT: Availability of alternative biomaterials

The global market growth may be hindered due to the presence of substitute biomaterials that offer efficient and reliable healing, repair, and regeneration of damaged or diseased tissue and organs. Various biomaterials, including chitosan, alginate, cellulose, hyaluronic acid, polylactic acid (PLA), poly(lactic-co-glycolic acid) (PLGA), are being utilized as alternatives to collagen and gelatin in the field of regenerative medicine. The availability of these substitutes has the potential to impede the progress of the market on a global scale.

OPPORTUNITY: Implementation of the 21st Century Cures Act

In December 2016, The 21st Century Cures Act was signed into law in the US. The Act is intended to help accelerate medical product development and bring innovations and advances to patients who need them faster and more efficiently. Under this Act, a new Regenerative Medicine Advanced Therapy designation is been instituted, along with a fast-track approvals for novel regenerative medicine products. The implementation of the 21st Century Cures Act is likely to potentially result in the approval of new regenerative medicine products in the US and promote research and development in the field of regenerative medicine.

CHALLENGE: Insufficient processing technologies

The process of extracting and processing collagen and gelatin proteins is highly advanced and requires sophisticated technology. Once the edible collagen is extracted from porcine, bovine, or fish skins, it undergoes filtration and ion exchange. The filtration process utilizes microfiltration technology, allowing the fluid to pass through a porous membrane. Heat sterilization is then applied, requiring high-temperature heat treatment, followed by drying the product through spray drying technology. Unfortunately, these technologies are not widely developed in many regions, particularly in developing countries such as India, China, and the Rest of Asia Pacific. Consequently, collagen peptides and gelatin production are limited to certain countries, such as the US, the UK, and Germany. Developing countries with high demand for protein-based ingredients are at a disadvantage due to the lack of advanced technologies for manufacturing and marketing these products.

Collagen and Gelatin Market Ecosystem

The orthopedic segment dominated the collagen and gelatin industry in 2022.

Based on application, the global collagen and gelatin market is segmented into wound care, dental, orthopedic, surgical, cardiovascular, and other collagen applications. The global gelatin market is segmented into orthopedics, wound care, and other gelatin application. The orthopedic segment accounted for the largest share of the both market. The dominant share is majorly due to the rising adoption of biomaterials in orthopedic surgeries and the launch of novel products in the market.

The hospitals segment of collagen and gelatin industry accounted for the segment-dominated market in 2022.

Based on end users, the collagen and gelatin market is segmented into hospitals and surgical centers. In 2022, the hospitals segment accounted for the largest share of the market. The segment held the dominant share in the market owing to various factors such as an increased number of surgical procedures across the globe and increased adoption of collagen-based products in orthopedic, wound care, dental and other applications.

North America held a dominant share in the regional market for the collagen and gelatin industry in 2022.

To know about the assumptions considered for the study, download the pdf brochure

Geographically, the collagen and gelatin market is segmented into North America, Europe, Asia Pacific, Rest of the World. In 2022, North America accounted for the largest share of the gelatin market, followed by Europe & Asia Pacific. The dominance of the region is attributable to various factors, such as the presence of top market players in the region, the presence of top medical facilities leading to the adoption of technologically advanced wound care products, and the increased number of surgeries in the region.

Key players in the Collagen and Gelatin market include Integra LifeSciences (US), DSM (Netherlands), CollPlant Biotechnologies Ltd. (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions PLC (UK), and others.

Scope of the Collagen and Gelatin Industry

This report categorizes the collagen and gelatin market to forecast revenue and analyze trends in each of the following submarkets:

By Source

• Bovine
• Porcine
• Other sources

By Application

• Orthopedic
• Wound Care
• Dental
• Surgical
• Cardiovascular Disease
• Others

By Application

• Orthopedic
• Wound Care
• Other Applications

By End User

• Hospitals
• Surgical Centers

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Rest of Europe (RoE)
• Asia Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of Asia Pacific (RoAPAC)
• Rest of World (RoW)
  • Latin America
  • Middle East and Africa (MEA)

Recent Developments of Collagen and Gelatin Industry

• In January 2023, TELA Bio, Inc. launched NIVIS Fibrillar Collagen Pack. NIVIS Fibrillar Collagen Pack is an absorbent matrix of Type I and Type III bovine collagen proposed to manage moderately to heavily exudating wounds and to control minor bleeding.
• In October 2022, Collagen Matrix acquired Polyganics B.V. expanded its portfolio of bioresorbable solutions and technology platforms for bone and tissue repair.
• In January 2021, Integra LifeSciences acquired ACell. This acquisition enabled the company to provide more comprehensive complex wound management solutions.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst